

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 7.95742238 |
| 2 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.46859241 |
| 3 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 6.06355048 |
| 4 | NADH metabolic process (GO:0006734) | 5.82934800 |
| 5 | regulation of cofactor metabolic process (GO:0051193) | 5.66619471 |
| 6 | regulation of coenzyme metabolic process (GO:0051196) | 5.66619471 |
| 7 | lysine metabolic process (GO:0006553) | 5.53250743 |
| 8 | lysine catabolic process (GO:0006554) | 5.53250743 |
| 9 | carnitine shuttle (GO:0006853) | 5.50753749 |
| 10 | succinate metabolic process (GO:0006105) | 5.25816031 |
| 11 | sarcomere organization (GO:0045214) | 5.10829353 |
| 12 | fatty acid transmembrane transport (GO:1902001) | 5.08940189 |
| 13 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.06615662 |
| 14 | aspartate family amino acid catabolic process (GO:0009068) | 5.01287424 |
| 15 | 2-oxoglutarate metabolic process (GO:0006103) | 4.99530231 |
| 16 | cardiac myofibril assembly (GO:0055003) | 4.97361843 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.81648366 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.80514917 |
| 19 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.76637718 |
| 20 | oxaloacetate metabolic process (GO:0006107) | 4.63647736 |
| 21 | regulation of sulfur metabolic process (GO:0042762) | 4.63415994 |
| 22 | fatty acid beta-oxidation (GO:0006635) | 4.62024010 |
| 23 | actin-myosin filament sliding (GO:0033275) | 4.54004809 |
| 24 | muscle filament sliding (GO:0030049) | 4.54004809 |
| 25 | oxidative phosphorylation (GO:0006119) | 4.50419500 |
| 26 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.49745038 |
| 27 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.49248052 |
| 28 | myofibril assembly (GO:0030239) | 4.41361094 |
| 29 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.36677073 |
| 30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.34244091 |
| 31 | skeletal muscle contraction (GO:0003009) | 4.32535485 |
| 32 | branched-chain amino acid catabolic process (GO:0009083) | 4.31585233 |
| 33 | cardiac muscle contraction (GO:0060048) | 4.31372524 |
| 34 | carnitine transmembrane transport (GO:1902603) | 4.24953701 |
| 35 | actin filament-based movement (GO:0030048) | 4.21058276 |
| 36 | tricarboxylic acid metabolic process (GO:0072350) | 4.20970136 |
| 37 | carnitine transport (GO:0015879) | 4.16229303 |
| 38 | amino-acid betaine transport (GO:0015838) | 4.16229303 |
| 39 | regulation of sequestering of triglyceride (GO:0010889) | 4.08603939 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 4.07056267 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.03079952 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 4.01060598 |
| 43 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.01060598 |
| 44 | * respiratory electron transport chain (GO:0022904) | 4.00905349 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.96705065 |
| 46 | regulation of sarcomere organization (GO:0060297) | 3.94555523 |
| 47 | cardiac muscle hypertrophy (GO:0003300) | 3.92066137 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91992466 |
| 49 | fatty acid oxidation (GO:0019395) | 3.91665699 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.91423591 |
| 51 | regulation of skeletal muscle contraction (GO:0014819) | 3.89408412 |
| 52 | * electron transport chain (GO:0022900) | 3.89268772 |
| 53 | short-chain fatty acid metabolic process (GO:0046459) | 3.86822366 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 3.86084845 |
| 55 | branched-chain amino acid metabolic process (GO:0009081) | 3.85926293 |
| 56 | lipid oxidation (GO:0034440) | 3.85690619 |
| 57 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.84181631 |
| 58 | regulation of fatty acid oxidation (GO:0046320) | 3.82070886 |
| 59 | regulation of actin filament-based movement (GO:1903115) | 3.76514672 |
| 60 | actin-mediated cell contraction (GO:0070252) | 3.75409699 |
| 61 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.74797330 |
| 62 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.73418706 |
| 63 | striated muscle hypertrophy (GO:0014897) | 3.72912676 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.67402850 |
| 65 | biotin metabolic process (GO:0006768) | 3.61798800 |
| 66 | creatine metabolic process (GO:0006600) | 3.59251098 |
| 67 | striated muscle contraction (GO:0006941) | 3.59205842 |
| 68 | response to muscle activity (GO:0014850) | 3.57978397 |
| 69 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.57332924 |
| 70 | ketone body metabolic process (GO:1902224) | 3.56810256 |
| 71 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.53331155 |
| 72 | cardiac muscle cell development (GO:0055013) | 3.53222329 |
| 73 | carnitine metabolic process (GO:0009437) | 3.52092455 |
| 74 | monocarboxylic acid catabolic process (GO:0072329) | 3.49904883 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.48935680 |
| 76 | response to inactivity (GO:0014854) | 3.44853822 |
| 77 | glyoxylate metabolic process (GO:0046487) | 3.44355790 |
| 78 | valine metabolic process (GO:0006573) | 3.44226026 |
| 79 | plasma membrane repair (GO:0001778) | 3.42783360 |
| 80 | cell communication involved in cardiac conduction (GO:0086065) | 3.42471404 |
| 81 | cell communication by electrical coupling (GO:0010644) | 3.41459133 |
| 82 | quaternary ammonium group transport (GO:0015697) | 3.38823472 |
| 83 | muscle contraction (GO:0006936) | 3.37110890 |
| 84 | regulation of membrane repolarization (GO:0060306) | 3.36585279 |
| 85 | muscle hypertrophy (GO:0014896) | 3.32432686 |
| 86 | actomyosin structure organization (GO:0031032) | 3.31587933 |
| 87 | fatty acid homeostasis (GO:0055089) | 3.27965339 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.22801058 |
| 89 | regulation of the force of heart contraction (GO:0002026) | 3.22274678 |
| 90 | cardiac cell development (GO:0055006) | 3.21522082 |
| 91 | regulation of striated muscle contraction (GO:0006942) | 3.19717819 |
| 92 | amino-acid betaine metabolic process (GO:0006577) | 3.19455066 |
| 93 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.14643051 |
| 94 | positive regulation of fatty acid oxidation (GO:0046321) | 3.12797112 |
| 95 | glycogen catabolic process (GO:0005980) | 3.11814611 |
| 96 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.11496318 |
| 97 | dicarboxylic acid catabolic process (GO:0043649) | 3.10929787 |
| 98 | gluconeogenesis (GO:0006094) | 3.10466672 |
| 99 | cardiac muscle adaptation (GO:0014887) | 3.09496160 |
| 100 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.09496160 |
| 101 | muscle hypertrophy in response to stress (GO:0003299) | 3.09496160 |
| 102 | adult heart development (GO:0007512) | 3.06684474 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.06436617 |
| 104 | quinone biosynthetic process (GO:1901663) | 3.05804710 |
| 105 | ubiquinone biosynthetic process (GO:0006744) | 3.05804710 |
| 106 | skeletal muscle adaptation (GO:0043501) | 3.05589340 |
| 107 | cardiac muscle cell action potential (GO:0086001) | 3.04832633 |
| 108 | thioester biosynthetic process (GO:0035384) | 3.03770360 |
| 109 | acyl-CoA biosynthetic process (GO:0071616) | 3.03770360 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.03060740 |
| 111 | heart process (GO:0003015) | 3.02874151 |
| 112 | heart contraction (GO:0060047) | 3.02874151 |
| 113 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.02152045 |
| 114 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.02098141 |
| 115 | muscle system process (GO:0003012) | 3.00995413 |
| 116 | muscle tissue morphogenesis (GO:0060415) | 2.95636569 |
| 117 | relaxation of cardiac muscle (GO:0055119) | 2.90812415 |
| 118 | glucan catabolic process (GO:0009251) | 2.88285603 |
| 119 | response to caffeine (GO:0031000) | 2.86467035 |
| 120 | muscle fiber development (GO:0048747) | 2.85309365 |
| 121 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.81363994 |
| 122 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.81363994 |
| 123 | positive regulation of cation channel activity (GO:2001259) | 2.80490113 |
| 124 | striated muscle adaptation (GO:0014888) | 2.79440916 |
| 125 | detection of calcium ion (GO:0005513) | 2.76335685 |
| 126 | skeletal muscle fiber development (GO:0048741) | 2.68174054 |
| 127 | myotube differentiation (GO:0014902) | 2.68152895 |
| 128 | cellular polysaccharide catabolic process (GO:0044247) | 2.65971325 |
| 129 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.64063930 |
| 130 | myotube cell development (GO:0014904) | 2.60534440 |
| 131 | striated muscle cell development (GO:0055002) | 2.60115494 |
| 132 | muscle cell cellular homeostasis (GO:0046716) | 2.59824885 |
| 133 | relaxation of muscle (GO:0090075) | 2.58245437 |
| 134 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56763572 |
| 135 | regulation of heart rate (GO:0002027) | 2.50227061 |
| 136 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.49330202 |
| 137 | cardiac conduction (GO:0061337) | 2.47202029 |
| 138 | glucan biosynthetic process (GO:0009250) | 2.46249331 |
| 139 | glycogen biosynthetic process (GO:0005978) | 2.46249331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.01400655 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.60236006 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.75521018 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.30673625 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.55095146 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.20233705 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.90787427 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90307321 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.87720798 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.81125694 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.48381344 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.42811398 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.41487278 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.34272750 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.15588685 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13898909 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02328112 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.97522940 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.97522940 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94381336 |
| 21 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86452442 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85325513 |
| 23 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.77828841 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73001437 |
| 25 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.71336920 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70721203 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69271112 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62347775 |
| 29 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.61045848 |
| 30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.56560458 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.53413201 |
| 32 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49092428 |
| 33 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.48105632 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45602429 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44611587 |
| 36 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.44555125 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40140326 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40114068 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.40105202 |
| 40 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37612218 |
| 41 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.35474750 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35454743 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34985195 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34112012 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30811355 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.30512580 |
| 47 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29418031 |
| 48 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.29405977 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28069684 |
| 50 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27119847 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26929707 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26441768 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25709027 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25288132 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24353257 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23858229 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23727335 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22492714 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21844311 |
| 60 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20892626 |
| 61 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.20154404 |
| 62 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19560578 |
| 63 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18129117 |
| 64 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.17833848 |
| 65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.16612046 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16115590 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15020549 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14907164 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12832881 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11091339 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10957180 |
| 72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09897139 |
| 73 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08918521 |
| 74 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08671318 |
| 75 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08569595 |
| 76 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08352903 |
| 77 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08229781 |
| 78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07406703 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05736656 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04629433 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03939036 |
| 82 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03938906 |
| 83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03518562 |
| 84 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01804897 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01506538 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01355105 |
| 87 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01217304 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99404877 |
| 89 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98873662 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98582274 |
| 91 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98347543 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98288025 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 0.97980409 |
| 94 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97068114 |
| 95 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96098172 |
| 96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96098172 |
| 97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95865074 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95806992 |
| 99 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95671697 |
| 100 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95613388 |
| 101 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95349677 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93639934 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93328517 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93328517 |
| 105 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93252290 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.92804808 |
| 107 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92523008 |
| 108 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.92491769 |
| 109 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92237725 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92140431 |
| 111 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91812009 |
| 112 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90596048 |
| 113 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89578681 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88773276 |
| 115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87789231 |
| 116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87785723 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84688677 |
| 118 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83902756 |
| 119 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82766630 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82348099 |
| 121 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.79826762 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79815953 |
| 123 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.78592278 |
| 124 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.77770639 |
| 125 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77680217 |
| 126 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77628713 |
| 127 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77628713 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76925366 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.76652662 |
| 130 | STAT3_23295773_ChIP-Seq_U87_Human | 0.75810818 |
| 131 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.74567789 |
| 132 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74150487 |
| 133 | FUS_26573619_Chip-Seq_HEK293_Human | 0.71639539 |
| 134 | AR_25329375_ChIP-Seq_VCAP_Human | 0.71086027 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.70080051 |
| 136 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69107538 |
| 137 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.69106287 |
| 138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.68969907 |
| 139 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.68498754 |
| 140 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.68026058 |
| 141 | TCF4_23295773_ChIP-Seq_U87_Human | 0.67822400 |
| 142 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.67526822 |
| 143 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.67526822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.74314814 |
| 2 | MP0003646_muscle_fatigue | 4.63633806 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.30870005 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.14432545 |
| 5 | MP0000751_myopathy | 4.12096549 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.57278850 |
| 7 | MP0000749_muscle_degeneration | 3.24205852 |
| 8 | MP0005330_cardiomyopathy | 3.20051966 |
| 9 | MP0004130_abnormal_muscle_cell | 3.05531267 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 2.68993872 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.63791533 |
| 12 | MP0005360_urolithiasis | 2.59769904 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.49592468 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.43911037 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.40626230 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.40018567 |
| 17 | MP0002139_abnormal_hepatobiliary_system | 2.31643663 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.30595365 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.22051534 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 2.20404526 |
| 21 | MP0005670_abnormal_white_adipose | 2.12814375 |
| 22 | MP0002269_muscular_atrophy | 2.10902320 |
| 23 | MP0004484_altered_response_of | 2.07691491 |
| 24 | MP0002106_abnormal_muscle_physiology | 1.99324458 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 1.98428424 |
| 26 | MP0005385_cardiovascular_system_phenoty | 1.98428424 |
| 27 | MP0004270_analgesia | 1.94596795 |
| 28 | MP0000747_muscle_weakness | 1.93652723 |
| 29 | MP0005365_abnormal_bile_salt | 1.93129862 |
| 30 | MP0006138_congestive_heart_failure | 1.88926178 |
| 31 | MP0006035_abnormal_mitochondrial_morpho | 1.87805685 |
| 32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.82878009 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.80790373 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.76891616 |
| 35 | MP0004043_abnormal_pH_regulation | 1.76510841 |
| 36 | MP0010630_abnormal_cardiac_muscle | 1.75901015 |
| 37 | MP0004085_abnormal_heartbeat | 1.75203855 |
| 38 | MP0005332_abnormal_amino_acid | 1.69470629 |
| 39 | MP0004147_increased_porphyrin_level | 1.64935569 |
| 40 | MP0005369_muscle_phenotype | 1.63887877 |
| 41 | MP0004233_abnormal_muscle_weight | 1.61825200 |
| 42 | MP0000759_abnormal_skeletal_muscle | 1.57367659 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.42597719 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.41700347 |
| 45 | MP0003195_calcinosis | 1.39300023 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32359496 |
| 47 | MP0002822_catalepsy | 1.25260984 |
| 48 | MP0002971_abnormal_brown_adipose | 1.24045400 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.19006120 |
| 50 | MP0005187_abnormal_penis_morphology | 1.18228931 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 1.16964369 |
| 52 | MP0005266_abnormal_metabolism | 1.15561446 |
| 53 | MP0000733_abnormal_muscle_development | 1.14722844 |
| 54 | MP0005535_abnormal_body_temperature | 1.14049249 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.12140765 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.11306234 |
| 57 | MP0003252_abnormal_bile_duct | 1.10042926 |
| 58 | MP0003941_abnormal_skin_development | 1.08988274 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.08592540 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08547287 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.02680368 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.02271636 |
| 63 | MP0001299_abnormal_eye_distance/ | 1.02015135 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.01397326 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 1.00216254 |
| 66 | MP0003828_pulmonary_edema | 0.99343125 |
| 67 | MP0002009_preneoplasia | 0.95301031 |
| 68 | MP0000230_abnormal_systemic_arterial | 0.92333797 |
| 69 | MP0008057_abnormal_DNA_replication | 0.88617893 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 0.88447932 |
| 71 | MP0009697_abnormal_copulation | 0.83481467 |
| 72 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82035105 |
| 73 | MP0001984_abnormal_olfaction | 0.81897735 |
| 74 | MP0003868_abnormal_feces_composition | 0.81877942 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.81142379 |
| 76 | MP0005386_behavior/neurological_phenoty | 0.80430684 |
| 77 | MP0004924_abnormal_behavior | 0.80430684 |
| 78 | MP0003045_fibrosis | 0.80015231 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.79477879 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.76541426 |
| 81 | MP0002108_abnormal_muscle_morphology | 0.76514342 |
| 82 | MP0009046_muscle_twitch | 0.72841696 |
| 83 | MP0000266_abnormal_heart_morphology | 0.70543055 |
| 84 | MP0001764_abnormal_homeostasis | 0.70420671 |
| 85 | MP0005165_increased_susceptibility_to | 0.69408001 |
| 86 | MP0005083_abnormal_biliary_tract | 0.67913334 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.66749457 |
| 88 | MP0005334_abnormal_fat_pad | 0.66445625 |
| 89 | MP0003329_amyloid_beta_deposits | 0.66141235 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.65675837 |
| 91 | MP0009745_abnormal_behavioral_response | 0.64757866 |
| 92 | MP0003879_abnormal_hair_cell | 0.62996663 |
| 93 | MP0000609_abnormal_liver_physiology | 0.62648004 |
| 94 | MP0001666_abnormal_nutrient_absorption | 0.61974442 |
| 95 | MP0001529_abnormal_vocalization | 0.61944161 |
| 96 | MP0001486_abnormal_startle_reflex | 0.61037439 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.60538612 |
| 98 | MP0009672_abnormal_birth_weight | 0.60217276 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.60081610 |
| 100 | MP0008569_lethality_at_weaning | 0.60021160 |
| 101 | MP0004859_abnormal_synaptic_plasticity | 0.59568266 |
| 102 | MP0005451_abnormal_body_composition | 0.58788508 |
| 103 | MP0003635_abnormal_synaptic_transmissio | 0.58195490 |
| 104 | MP0005448_abnormal_energy_balance | 0.57996888 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.57112338 |
| 106 | MP0002272_abnormal_nervous_system | 0.57036382 |
| 107 | MP0000343_altered_response_to | 0.56768402 |
| 108 | MP0002734_abnormal_mechanical_nocicepti | 0.56125894 |
| 109 | MP0005452_abnormal_adipose_tissue | 0.54975495 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.54808228 |
| 111 | MP0003136_yellow_coat_color | 0.54685843 |
| 112 | MP0003186_abnormal_redox_activity | 0.53637413 |
| 113 | MP0002064_seizures | 0.53449094 |
| 114 | MP0001440_abnormal_grooming_behavior | 0.52485670 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.51946229 |
| 116 | MP0001661_extended_life_span | 0.51481779 |
| 117 | MP0003880_abnormal_central_pattern | 0.50331058 |
| 118 | MP0004510_myositis | 0.50233427 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.49718950 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.49508542 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.49266997 |
| 122 | MP0001756_abnormal_urination | 0.48765353 |
| 123 | MP0004272_abnormal_basement_membrane | 0.48631641 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.48471318 |
| 125 | MP0002066_abnormal_motor_capabilities/c | 0.48145975 |
| 126 | MP0004142_abnormal_muscle_tone | 0.47992343 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.46920782 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.46357123 |
| 129 | MP0002128_abnormal_blood_circulation | 0.45542904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.27236160 |
| 2 | Myoglobinuria (HP:0002913) | 5.27024272 |
| 3 | Exercise-induced myalgia (HP:0003738) | 5.16394038 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 5.03720708 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.52014649 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.29117013 |
| 7 | Distal arthrogryposis (HP:0005684) | 4.23984095 |
| 8 | Rhabdomyolysis (HP:0003201) | 4.20304357 |
| 9 | Ketoacidosis (HP:0001993) | 4.00197825 |
| 10 | Hepatic necrosis (HP:0002605) | 3.96672410 |
| 11 | Ventricular tachycardia (HP:0004756) | 3.90418928 |
| 12 | Increased serum pyruvate (HP:0003542) | 3.88348165 |
| 13 | Abnormality of glycolysis (HP:0004366) | 3.88348165 |
| 14 | Hypoglycemic coma (HP:0001325) | 3.83173752 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.81751877 |
| 16 | Palpitations (HP:0001962) | 3.71981660 |
| 17 | Atrial fibrillation (HP:0005110) | 3.67723626 |
| 18 | Hyperglycinuria (HP:0003108) | 3.63272974 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 3.59975912 |
| 20 | * Abnormal mitochondria in muscle tissue (HP:0008316) | 3.58513991 |
| 21 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.49749835 |
| 22 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.48246299 |
| 23 | Dicarboxylic aciduria (HP:0003215) | 3.48246299 |
| 24 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.45288161 |
| 25 | Abnormality of alanine metabolism (HP:0010916) | 3.45288161 |
| 26 | Hyperalaninemia (HP:0003348) | 3.45288161 |
| 27 | Ketosis (HP:0001946) | 3.43513925 |
| 28 | Hepatocellular necrosis (HP:0001404) | 3.43000642 |
| 29 | Frequent falls (HP:0002359) | 3.38315134 |
| 30 | Primary atrial arrhythmia (HP:0001692) | 3.38081311 |
| 31 | Lipoatrophy (HP:0100578) | 3.35962118 |
| 32 | Neck muscle weakness (HP:0000467) | 3.35195259 |
| 33 | * Acute encephalopathy (HP:0006846) | 3.35168210 |
| 34 | Muscle fiber splitting (HP:0003555) | 3.34492933 |
| 35 | * Cerebral edema (HP:0002181) | 3.33234204 |
| 36 | * Acute necrotizing encephalopathy (HP:0006965) | 3.32536915 |
| 37 | Hyperammonemia (HP:0001987) | 3.28379131 |
| 38 | Supraventricular tachycardia (HP:0004755) | 3.27679274 |
| 39 | Myopathic facies (HP:0002058) | 3.23893171 |
| 40 | Syncope (HP:0001279) | 3.21502171 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.20176054 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20176054 |
| 43 | Supraventricular arrhythmia (HP:0005115) | 3.19906739 |
| 44 | Pheochromocytoma (HP:0002666) | 3.14185524 |
| 45 | Dilated cardiomyopathy (HP:0001644) | 3.12305280 |
| 46 | Hyporeflexia of lower limbs (HP:0002600) | 3.07110943 |
| 47 | Right ventricular cardiomyopathy (HP:0011663) | 3.02366605 |
| 48 | * Increased CSF lactate (HP:0002490) | 3.00557164 |
| 49 | Subaortic stenosis (HP:0001682) | 2.96967007 |
| 50 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.96967007 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.96704499 |
| 52 | * Lactic acidosis (HP:0003128) | 2.94175010 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.89825966 |
| 54 | EMG: neuropathic changes (HP:0003445) | 2.89434067 |
| 55 | EMG: myopathic abnormalities (HP:0003458) | 2.88082230 |
| 56 | Round ear (HP:0100830) | 2.85831981 |
| 57 | Neuroendocrine neoplasm (HP:0100634) | 2.84773625 |
| 58 | * Mitochondrial inheritance (HP:0001427) | 2.80040137 |
| 59 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.78873520 |
| 60 | * Progressive macrocephaly (HP:0004481) | 2.78166755 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.78161996 |
| 62 | Ventricular arrhythmia (HP:0004308) | 2.73849374 |
| 63 | Muscle stiffness (HP:0003552) | 2.72679993 |
| 64 | Bundle branch block (HP:0011710) | 2.69821336 |
| 65 | Prolonged QT interval (HP:0001657) | 2.69769646 |
| 66 | Areflexia of lower limbs (HP:0002522) | 2.68561211 |
| 67 | Hyperglycinemia (HP:0002154) | 2.67237474 |
| 68 | Increased connective tissue (HP:0009025) | 2.59427382 |
| 69 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.58796215 |
| 70 | Metabolic acidosis (HP:0001942) | 2.58180321 |
| 71 | Dysmetric saccades (HP:0000641) | 2.57379156 |
| 72 | Asymmetric septal hypertrophy (HP:0001670) | 2.56749340 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 2.56070481 |
| 74 | Myotonia (HP:0002486) | 2.55625735 |
| 75 | Conjunctival hamartoma (HP:0100780) | 2.54401106 |
| 76 | Neoplasm of the adrenal gland (HP:0100631) | 2.53879214 |
| 77 | Difficulty running (HP:0009046) | 2.53873129 |
| 78 | * Lethargy (HP:0001254) | 2.52860849 |
| 79 | Muscle fiber inclusion bodies (HP:0100299) | 2.44459814 |
| 80 | Proximal tubulopathy (HP:0000114) | 2.42773807 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.41087137 |
| 82 | Heart block (HP:0012722) | 2.40984712 |
| 83 | Calcaneovalgus deformity (HP:0001848) | 2.39758761 |
| 84 | Atrioventricular block (HP:0001678) | 2.38104238 |
| 85 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.34174302 |
| 86 | * Exercise intolerance (HP:0003546) | 2.33598902 |
| 87 | * Respiratory failure (HP:0002878) | 2.33172544 |
| 88 | Limb-girdle muscle atrophy (HP:0003797) | 2.31487867 |
| 89 | Ulnar deviation of the wrist (HP:0003049) | 2.31226696 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.30725703 |
| 91 | Generalized muscle weakness (HP:0003324) | 2.27809829 |
| 92 | Increased variability in muscle fiber diameter (HP:0003557) | 2.27073763 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26543971 |
| 94 | Gout (HP:0001997) | 2.23926639 |
| 95 | Increased serum lactate (HP:0002151) | 2.23738397 |
| 96 | Scapular winging (HP:0003691) | 2.22845701 |
| 97 | Rimmed vacuoles (HP:0003805) | 2.21324178 |
| 98 | Hypoalphalipoproteinemia (HP:0003233) | 2.21255750 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.18636653 |
| 100 | Methylmalonic aciduria (HP:0012120) | 2.14162099 |
| 101 | Ventricular fibrillation (HP:0001663) | 2.13987355 |
| 102 | Cholelithiasis (HP:0001081) | 2.13047245 |
| 103 | * Vomiting (HP:0002013) | 2.12386722 |
| 104 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12288003 |
| 105 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12288003 |
| 106 | Hyperkalemia (HP:0002153) | 2.10938975 |
| 107 | Absent phalangeal crease (HP:0006109) | 2.09810639 |
| 108 | Type 1 muscle fiber predominance (HP:0003803) | 2.09118418 |
| 109 | Renal cortical cysts (HP:0000803) | 2.08519287 |
| 110 | Left ventricular hypertrophy (HP:0001712) | 2.07768545 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07389847 |
| 112 | CNS demyelination (HP:0007305) | 2.07246114 |
| 113 | Abnormal finger flexion creases (HP:0006143) | 2.03663439 |
| 114 | Hamartoma of the eye (HP:0010568) | 2.02172473 |
| 115 | Central scotoma (HP:0000603) | 2.01858294 |
| 116 | Deformed tarsal bones (HP:0008119) | 2.01049087 |
| 117 | Hyperuricemia (HP:0002149) | 1.99867425 |
| 118 | Increased purine levels (HP:0004368) | 1.99867425 |
| 119 | Nausea (HP:0002018) | 1.99833842 |
| 120 | Fetal akinesia sequence (HP:0001989) | 1.99277160 |
| 121 | Proximal amyotrophy (HP:0007126) | 1.98560620 |
| 122 | Abnormal EKG (HP:0003115) | 1.97911934 |
| 123 | Nemaline bodies (HP:0003798) | 1.97387565 |
| 124 | Athetosis (HP:0002305) | 1.96444274 |
| 125 | Distal lower limb amyotrophy (HP:0008944) | 1.93112991 |
| 126 | Abnormality of the foot musculature (HP:0001436) | 1.88976042 |
| 127 | Malignant hyperthermia (HP:0002047) | 1.87839146 |
| 128 | Lower limb amyotrophy (HP:0007210) | 1.81677997 |
| 129 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.80877520 |
| 130 | Gowers sign (HP:0003391) | 1.77567318 |
| 131 | Steppage gait (HP:0003376) | 1.73577035 |
| 132 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73037819 |
| 133 | Muscular dystrophy (HP:0003560) | 1.72586775 |
| 134 | Shoulder girdle muscle weakness (HP:0003547) | 1.69306030 |
| 135 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.69193163 |
| 136 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.69193163 |
| 137 | Progressive muscle weakness (HP:0003323) | 1.62228369 |
| 138 | Papillary thyroid carcinoma (HP:0002895) | 1.60887885 |
| 139 | Limb-girdle muscle weakness (HP:0003325) | 1.59502410 |
| 140 | Foot dorsiflexor weakness (HP:0009027) | 1.58986316 |
| 141 | Long clavicles (HP:0000890) | 1.57485046 |
| 142 | Hip contracture (HP:0003273) | 1.55895760 |
| 143 | Pelvic girdle muscle weakness (HP:0003749) | 1.49485210 |
| 144 | Limited hip movement (HP:0008800) | 1.47470374 |
| 145 | Abnormality of potassium homeostasis (HP:0011042) | 1.44860546 |
| 146 | Abnormality of the calcaneus (HP:0008364) | 1.42336687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 5.20767612 |
| 2 | PDK3 | 5.20767612 |
| 3 | OBSCN | 4.38688325 |
| 4 | NEK1 | 4.08907635 |
| 5 | BCKDK | 3.94957609 |
| 6 | TTN | 3.73960748 |
| 7 | LMTK2 | 3.37799554 |
| 8 | PHKG1 | 3.21239686 |
| 9 | PHKG2 | 3.21239686 |
| 10 | PDK2 | 3.13252394 |
| 11 | MYLK | 2.48436797 |
| 12 | PKN2 | 2.41756972 |
| 13 | PINK1 | 2.33375828 |
| 14 | MARK1 | 1.92545685 |
| 15 | EEF2K | 1.77662950 |
| 16 | TRIB3 | 1.71234185 |
| 17 | PIK3CA | 1.60895174 |
| 18 | WNK4 | 1.57068175 |
| 19 | STK24 | 1.56811078 |
| 20 | MAP2K4 | 1.54459882 |
| 21 | TIE1 | 1.50533841 |
| 22 | INSRR | 1.39729034 |
| 23 | ERBB3 | 1.33056720 |
| 24 | STK38L | 1.31368906 |
| 25 | ACVR1B | 1.28599836 |
| 26 | MAP3K4 | 1.25753847 |
| 27 | FRK | 1.24144210 |
| 28 | TRPM7 | 1.16532256 |
| 29 | CASK | 1.14632592 |
| 30 | BRSK2 | 1.12363060 |
| 31 | GRK7 | 1.10462129 |
| 32 | SCYL2 | 1.07449863 |
| 33 | MAP3K7 | 1.02923596 |
| 34 | DMPK | 1.02389463 |
| 35 | ICK | 1.01792273 |
| 36 | LATS1 | 1.00512789 |
| 37 | CCNB1 | 1.00331910 |
| 38 | WNK3 | 1.00121333 |
| 39 | CAMK2D | 0.97744688 |
| 40 | FLT3 | 0.95999533 |
| 41 | NME1 | 0.95870364 |
| 42 | NTRK3 | 0.95597524 |
| 43 | EPHA4 | 0.95239846 |
| 44 | LATS2 | 0.94762947 |
| 45 | MAPK12 | 0.93954733 |
| 46 | MAPKAPK3 | 0.92984452 |
| 47 | PBK | 0.90574252 |
| 48 | MET | 0.90478348 |
| 49 | PAK3 | 0.89879982 |
| 50 | PRKAA1 | 0.89211605 |
| 51 | SGK2 | 0.87903791 |
| 52 | LIMK1 | 0.84662784 |
| 53 | MUSK | 0.83057890 |
| 54 | BMPR1B | 0.82759522 |
| 55 | EPHA3 | 0.80851875 |
| 56 | OXSR1 | 0.80584927 |
| 57 | MAP2K7 | 0.78991220 |
| 58 | TTK | 0.76610592 |
| 59 | SGK3 | 0.74341725 |
| 60 | NEK9 | 0.74284742 |
| 61 | SGK223 | 0.73989253 |
| 62 | SGK494 | 0.73989253 |
| 63 | PRKAA2 | 0.72731345 |
| 64 | ZAK | 0.72501202 |
| 65 | CAMK2A | 0.70790931 |
| 66 | STK39 | 0.67420638 |
| 67 | MST1R | 0.66785822 |
| 68 | RPS6KB1 | 0.66065930 |
| 69 | ROCK1 | 0.65616084 |
| 70 | TSSK6 | 0.65442224 |
| 71 | AKT3 | 0.65242541 |
| 72 | CAMK2G | 0.62972267 |
| 73 | MAP3K12 | 0.62556290 |
| 74 | CAMKK2 | 0.59280179 |
| 75 | PRKD1 | 0.57116723 |
| 76 | PNCK | 0.56897798 |
| 77 | MAP3K5 | 0.54809904 |
| 78 | CAMK4 | 0.54461345 |
| 79 | CAMK1G | 0.54440197 |
| 80 | MINK1 | 0.52797238 |
| 81 | STK38 | 0.52658463 |
| 82 | PRKACG | 0.52591515 |
| 83 | PRKACB | 0.52321971 |
| 84 | MAP3K6 | 0.51811688 |
| 85 | ILK | 0.51637404 |
| 86 | WNK1 | 0.51283715 |
| 87 | PLK2 | 0.50772722 |
| 88 | SIK1 | 0.50629111 |
| 89 | PRKCG | 0.50190836 |
| 90 | RPS6KB2 | 0.49751292 |
| 91 | PRKACA | 0.48278354 |
| 92 | MAPK10 | 0.47740009 |
| 93 | PDPK1 | 0.47659579 |
| 94 | PDK1 | 0.47428338 |
| 95 | CSNK1G1 | 0.47253538 |
| 96 | NTRK1 | 0.46251286 |
| 97 | FGFR3 | 0.45572819 |
| 98 | BCR | 0.45177816 |
| 99 | DAPK2 | 0.44434579 |
| 100 | RET | 0.44354583 |
| 101 | CSNK1E | 0.44287684 |
| 102 | MAP2K3 | 0.44138845 |
| 103 | MAPK11 | 0.44107813 |
| 104 | AKT2 | 0.42037298 |
| 105 | CSNK1A1L | 0.40857965 |
| 106 | CAMK1 | 0.40771470 |
| 107 | SGK1 | 0.40012634 |
| 108 | CSNK1G2 | 0.39038871 |
| 109 | PTK2B | 0.38546393 |
| 110 | PRKG1 | 0.38438607 |
| 111 | PRKCE | 0.38308767 |
| 112 | EIF2AK1 | 0.38180445 |
| 113 | EIF2AK3 | 0.38027780 |
| 114 | PRKDC | 0.36283995 |
| 115 | CAMK2B | 0.36152179 |
| 116 | CDC42BPA | 0.35826626 |
| 117 | KSR2 | 0.35372735 |
| 118 | MAP2K1 | 0.35067648 |
| 119 | CAMK1D | 0.33895777 |
| 120 | PIK3CG | 0.33691100 |
| 121 | DAPK3 | 0.32691778 |
| 122 | CDK5 | 0.32617774 |
| 123 | TNIK | 0.32366765 |
| 124 | PRKD3 | 0.31439792 |
| 125 | KSR1 | 0.30388943 |
| 126 | MAPK7 | 0.30063025 |
| 127 | ROCK2 | 0.29247440 |
| 128 | RPS6KA3 | 0.28058242 |
| 129 | FER | 0.27019708 |
| 130 | DAPK1 | 0.25741800 |
| 131 | FGFR1 | 0.25669140 |
| 132 | PAK6 | 0.23725310 |
| 133 | PRPF4B | 0.23457265 |
| 134 | PKN1 | 0.22351900 |
| 135 | PDGFRA | 0.20879924 |
| 136 | ERBB4 | 0.19290741 |
| 137 | PRKCH | 0.18972188 |
| 138 | MAP2K6 | 0.18647708 |
| 139 | RIPK1 | 0.17924243 |
| 140 | FGFR4 | 0.17791154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.72454138 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.44302274 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.86230713 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39293885 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.29010072 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.07147556 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.80015433 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.73891935 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.73507250 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.62471049 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.45746922 |
| 12 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.22701043 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.22492994 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.07003573 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06607264 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70837822 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.69036325 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63847392 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63271349 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60518580 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59963697 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57641581 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51040785 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.49004472 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.48685802 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46040426 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.43203968 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37887766 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33981597 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25716471 |
| 31 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25006410 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23550071 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15398814 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13290605 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12873948 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05523511 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02379966 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01475335 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.95989402 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95276669 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93023279 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90925703 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83632729 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81167644 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79360408 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 0.77999548 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77785386 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 0.75371070 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75076411 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74995469 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72725417 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65145559 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61348816 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61248869 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.59654649 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59533414 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58069850 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.57182429 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57114556 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.56993551 |
| 61 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56498467 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55794891 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.54659727 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.54267556 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52566408 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52208128 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51903168 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51801242 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51505593 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49878647 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48798430 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48580621 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46975660 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46371546 |
| 75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46291734 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45703087 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44193853 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41772649 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41297046 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39857026 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38597620 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36670699 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36139375 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.35579290 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34243036 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.33606928 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31962046 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.31595064 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.29938528 |
| 90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.29855621 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29636224 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29359945 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.28876294 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.28051111 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.27919522 |
| 96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.27529031 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27392419 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.27381340 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26932867 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26795167 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26511957 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.25961930 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25899693 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25752750 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25692635 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24857246 |
| 107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24410883 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23285460 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22629201 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22045954 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.19286126 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17724389 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17721810 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.16395373 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15761329 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14363300 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13613057 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.12987984 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.12455801 |
| 120 | Long-term potentiation_Homo sapiens_hsa04720 | 0.12043277 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11800565 |

